Hofheim am Taunus, Germany

Herbert Siegel


Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Kelkheim, DE (1987)
  • Hofheim am Taunus, DE (1988 - 1992)
  • Hofheim/Taunus, DE (1992)

Company Filing History:


Years Active: 1987-1992

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Herbert Siegel: A Trailblazer in Pharmaceutical Innovations

Introduction

Herbert Siegel is a distinguished inventor based in Hofheim am Taunus, Germany. With an impressive portfolio of 13 patents, he has made significant contributions to the field of pharmaceuticals and radiation-sensitive compounds. His innovative spirit and dedication to research have established him as a notable figure in the industry.

Latest Patents

Among his latest patents, Siegel has developed pharmaceutical products containing derivatives of 7-diphenylmethylenebicycloheptane or 7-diphenylmethylenebicycloheptene. These compounds are described for their use as hypolipidemics, which are intended to lower lipid levels in the body. Furthermore, he has introduced new derivatives and their physiologically tolerated acid addition salts, along with processes for their preparation.

Another notable patent from Siegel includes novel radiation-sensitive compounds, which are esters or amides derived from 1,2-naphthoquinone-(2)-diazide-4-sulfonic acid. These compounds are characterized by versatile chemical structures that can play a critical role in various applications within the field of photolithography.

Career Highlights

Herbert Siegel’s career has been largely associated with Hoechst Aktiengesellschaft, where he has utilized his expertise to develop groundbreaking inventions. His relentless pursuit of innovation has not only advanced pharmaceutical sciences but has also paved the way for future research and development in numerous applications.

Collaborations

Throughout his career, Siegel has collaborated with notable colleagues such as Klaus-Dieter Kampe and Hermann J Gerhards. These collaborations have fostered a dynamic research environment and contributed to the successful creation of several impactful patents. Working together, they have inspired each other to push the boundaries of modern science and technology.

Conclusion

In conclusion, Herbert Siegel stands out as a remarkable inventor whose work in pharmaceuticals and radiation-sensitive compounds has significantly impacted the industry. His substantial patent portfolio and fruitful collaborations highlight his dedication to innovation and excellence. As the scientific community continues to evolve, Siegel's contributions will undoubtedly remain influential in shaping the future of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…